The largest database of trusted experimental protocols

Matrigel growth factor reduced basement membrane matrix

Manufactured by Ibidi
Sourced in United Kingdom

Matrigel® Growth Factor Reduced Basement Membrane Matrix is a gelatinous protein mixture that resembles the complex extracellular environment found in many tissues. It is derived from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins.

Automatically generated - may contain errors

2 protocols using matrigel growth factor reduced basement membrane matrix

1

Angiogenic Potential of SARS-CoV-2 S Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CAECs were seeded on the top of Matrigel (Corning® Matrigel® Growth Factor Reduced Basement Membrane Matrix, cat# 356231) either in monoculture (4000 cells/well) or in coculture with PCs (4000 CAECs + 1500 PC/well), using Angiogenesis μ-Slides (IBIDI, U.K.) and growth factors-free medium. The S protein (1 μg/ml – 5.8 nM) or PBS vehicle were added to the system. Images were taken after 5 h using an inverted Leica microscope equipped with a 5× objective. The total tube length per imaging field was measured using ImageJ. To assess the interaction between PCs and CAECs, PCs were labelled with the red fluorescent tracker VybrantDiI Cell-Labeling Solution (Invitrogen; dilution 1:1000 in PBS, incubation for 5 min at 37°C followed by 15 min at 4°C). For experiments requiring the CD147 blockade, 100000 PCs in a total volume of 100 μl were pre-incubated with the anti-CD147 antibody (20 μg/ml) for 1 h at 20°C. Per each patient, experiments were performed in triplicates.
+ Open protocol
+ Expand
2

Angiogenic Potential of SPARC and APC-CM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human coronary artery ECs (CAECs, Promocell) were seeded on the top of Matrigel (Corning® Matrigel® Growth Factor Reduced Basement Membrane Matrix) (4,000 cells/well) using Angiogenesis μ-Slides (IBIDI, UK). APC-CM was diluted 1:1 with fresh EBM2 medium. EBM2 was used as control. Recombinant SPARC (Peprotech, UK) was diluted in EBM2. Images were snapped after 5 hours, and the total tube length per imaging field was measured.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!